Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Replimune Group, Inc. (REPL)Equibles does not estimate personal net worth.
Get an email with a short summary when Replimune Group, Inc. publishes a filing, an earnings call transcript or a press release.
Get REPL alertsArlene Goldenberg is recorded as Head of Investor Relations at Replimune Group, Inc. (REPL). Arlene Goldenberg has spoken on 1 earnings call across 1 company, most recently for Replimune Group, Inc. on October 28, 2026. Replimune Group, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Replimune Group, Inc. includes Dr. Sushil Patel (CEO and Board Member), Sushil Patel (CEO and Board Member), Dieter Weinand (Chairman and Board Member) and 7 others.
“Earlier today, we issued a press release reporting our financial results for the fiscal second quarter ended September 30, 2026.”
Biotechnology · Healthcare
Head of Investor Relations